naringenin and Endometrial Hyperplasia

naringenin has been researched along with Endometrial Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Liu, J; Xu, W	1

Other Studies

1 other study(ies) available for naringenin and Endometrial Hyperplasia

Article	Year
Naringenin and morin reduces insulin resistance and endometrial hyperplasia in the rat model of polycystic ovarian syndrome through enhancement of inflammation and autophagic apoptosis. Acta biochimica Polonica, 2022, Feb-10, Volume: 69, Issue:1 Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cell Line, Tumor; Cytokines; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Flavanones; Flavonoids; Humans; Inflammation; Insulin Resistance; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Polycystic Ovary Syndrome; Rats; Signal Transduction	2022

Article

Year

Naringenin and morin reduces insulin resistance and endometrial hyperplasia in the rat model of polycystic ovarian syndrome through enhancement of inflammation and autophagic apoptosis.

Acta biochimica Polonica, 2022, Feb-10, Volume: 69, Issue:1

Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cell Line, Tumor; Cytokines; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Flavanones; Flavonoids; Humans; Inflammation; Insulin Resistance; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Polycystic Ovary Syndrome; Rats; Signal Transduction

2022